Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Neurol. 2008 Oct;21(5):555-62.

    Intravenous immunoglobulins in the treatment of immune neuropathies.

    Source

    Department of Neurology, Heinrich-Heine-University, Duesseldorf, Germany. bernd.kieseier@uni-duesseldorf.de

    Abstract

    PURPOSE OF REVIEW:

    The aim of this review is to describe the value of high-dose polyclonal intravenous immunoglobulins as a treatment option in autoimmune disorders affecting the peripheral nervous system.

    RECENT FINDINGS:

    A randomized placebo-controlled trial in patients with chronic inflammatory demyelinating polyradiculoneuropathy revealed short-term and long-term efficacy and safety of intravenous immunoglobulins as a treatment option for the chronically inflamed peripheral nervous system. Case reports suggest that the subcutaneous administration of immunoglobulins may represent a convenient alternative.

    SUMMARY:

    Intravenous immunoglobulin represents an effective and safe treatment option in patients with autoimmune-mediated diseases affecting the peripheral nerves.

    PMID:
    18769249
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk